Recently, the State Drug Administration passed a priority review and approval procedure to conditionally approve the marketing of tengotinib tablets, a Class 1 innovative drug declared by Pharmaceutical Jiekang Technology Co., Ltd. This drug is used to treat adult patients with advanced, metastatic, or inoperable cholangiocarcinoma who have received systemic treatment and FGFR inhibitor treatment and have fibroblast growth factor receptor 2 fusion or rearrangement. The launch of this drug provides patients with new treatment options. Recently, the State Drug Administration approved the marketing of the traditional Chinese medicine Class 1.1 innovative medicine pediatric laxative granules declared by Jichuan Pharmaceutical Group Co., Ltd. This drug is the first innovative traditional Chinese medicine as the main treatment after the publication of the “Special Regulations on the Registration and Administration of Traditional Chinese Medicine”. It has the effect of strengthening the spleen and preventing laxation. It is used for children with constipation in traditional Chinese medicine with symptoms such as dry stools, difficulty defecating, red tongue, thick moss, and smooth pulse. The launch of this drug provides a new option for treating constipation in children.

Recently, the State Drug Administration passed a priority review and approval procedure to conditionally approve the marketing of tengotinib tablets, a Class 1 innovative drug declared by Pharmaceutical Jiekang Technology Co., Ltd. This drug is used to treat adult patients with advanced, metastatic, or inoperable cholangiocarcinoma who have received systemic treatment and FGFR inhibitor treatment and have fibroblast growth factor receptor 2 fusion or rearrangement. The launch of this drug provides patients with new treatment options. Recently, the State Drug Administration approved the marketing of the traditional Chinese medicine Class 1.1 innovative medicine pediatric laxative granules declared by Jichuan Pharmaceutical Group Co., Ltd. This drug is the first innovative traditional Chinese medicine as the main treatment after the publication of the “Special Regulations on the Registration and Administration of Traditional Chinese Medicine”. It has the effect of strengthening the spleen and preventing laxation. It is used in traditional Chinese medicine for constipation in children with symptoms such as dry stools, difficult bowel movements, red tongue, thick moss, and smooth pulse. The launch of this drug provides a new option for treating constipation in children.